4
Changes in Ownership
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-032073
Options or other derivatives
- General Counsel/Secretary acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Lineage Cell Therapeutics, Inc. Filed Acc 0001209191-19-032073
Options or other derivatives
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…